• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
variants in a large cohort of Chinese patients with congenital hypogonadotropic hypogonadism.在中国先天性低促性腺激素性性腺功能减退症大队列患者中发现的变异。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Jul 28;47(7):847-857. doi: 10.11817/j.issn.1672-7347.2022.220071.
2
Expanding the mutational spectrum of monogenic hypogonadotropic hypogonadism: novel mutations in ANOS1 and FGFR1 genes.扩大单基因性性腺功能减退症的突变谱:ANO1 和 FGFR1 基因的新突变。
Reprod Biol Endocrinol. 2020 Jan 29;18(1):8. doi: 10.1186/s12958-020-0568-6.
3
Expanding the genetic spectrum of ANOS1 mutations in patients with congenital hypogonadotropic hypogonadism.扩大先天性低促性腺激素性性腺功能减退患者中ANOS1突变的基因谱。
Hum Reprod. 2017 Mar 1;32(3):704-711. doi: 10.1093/humrep/dew354.
4
GnRH Deficient Patients With Congenital Hypogonadotropic Hypogonadism: Novel Genetic Findings in , and Genes in a Case Series and Review of the Literature.先天性低促性腺激素性性腺功能减退的促性腺激素释放激素缺乏患者:病例系列中、基因的新遗传学发现及文献综述
Front Endocrinol (Lausanne). 2020 Aug 28;11:626. doi: 10.3389/fendo.2020.00626. eCollection 2020.
5
Correlations Among Genotype and Outcome in Chinese Male Patients With Congenital Hypogonadotropic Hypogonadism Under HCG Treatment.中国先天性低促性腺激素性性腺功能减退症男性患者在 HCG 治疗下的基因型与结局的相关性。
J Sex Med. 2020 Apr;17(4):645-657. doi: 10.1016/j.jsxm.2020.01.011. Epub 2020 Mar 12.
6
Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann Syndrome.先天性低促性腺激素性性腺功能减退伴嗅觉缺失和 Gorlin 特征,由 PTCH1 突变引起,揭示了 Kallmann 综合征的一个新候选基因。
Neuroendocrinology. 2021;111(1-2):99-114. doi: 10.1159/000506640. Epub 2020 Feb 20.
7
Evaluating CHARGE syndrome in congenital hypogonadotropic hypogonadism patients harboring CHD7 variants.评估患有 CHD7 变异的先天性低促性腺激素性性腺功能减退症患者中的 CHARGE 综合征。
Genet Med. 2018 Aug;20(8):872-881. doi: 10.1038/gim.2017.197. Epub 2017 Nov 16.
8
Genotypic and phenotypic spectrum of CCDC141 variants in a Chinese cohort with congenital hypogonadotropic hypogonadism.在中国先天性低促性腺激素性性腺功能减退症患者队列中研究 CCDC141 变异的基因型和表型谱。
Eur J Endocrinol. 2020 Sep;183(3):245-254. doi: 10.1530/EJE-19-1018.
9
Analysis of genetic and clinical characteristics of a Chinese Kallmann syndrome cohort with mutations.具有突变的中国卡尔曼综合征队列的遗传和临床特征分析
Eur J Endocrinol. 2017 Oct;177(4):389-398. doi: 10.1530/EJE-17-0335. Epub 2017 Aug 5.
10
Classification of Rare Variants in Chinese Congenital Hypogonadotropic Hypogonadism Patients and Analysis of Their Clinical Characteristics.中国先天性低促性腺激素性性腺功能减退症患者罕见变异的分类及其临床特征分析
Front Genet. 2022 Jan 3;12:770680. doi: 10.3389/fgene.2021.770680. eCollection 2021.

引用本文的文献

1
Two cases of Kallmann syndrome caused by a novel mutation in ANOS1: A case report.两例由ANOS1基因新突变引起的卡尔曼综合征:病例报告。
Medicine (Baltimore). 2025 Apr 18;104(16):e42139. doi: 10.1097/MD.0000000000042139.

本文引用的文献

1
New findings in oligogenic inheritance of congenital hypogonadotropic hypogonadism.先天性低促性腺激素性性腺功能减退的寡基因遗传新发现。
Arch Med Sci. 2020 Sep 18;18(2):353-364. doi: 10.5114/aoms.2020.98909. eCollection 2022.
2
Advances in Genetic Diagnosis of Kallmann Syndrome and Genetic Interruption.卡尔曼综合征的遗传学诊断进展与基因阻断
Reprod Sci. 2022 Jun;29(6):1697-1709. doi: 10.1007/s43032-021-00638-8. Epub 2021 Jul 6.
3
Eight rare urinary disorders in a patient with Kallmann syndrome: A case report.卡尔曼综合征患者的八种罕见泌尿系统疾病:病例报告
Medicine (Baltimore). 2020 Oct 23;99(43):e22936. doi: 10.1097/MD.0000000000022936.
4
Anosmin-1 activates vascular endothelial growth factor receptor and its related signaling pathway for olfactory bulb angiogenesis.Anosmin-1 通过激活血管内皮生长因子受体及其相关信号通路促进嗅球血管生成。
Sci Rep. 2020 Jan 13;10(1):188. doi: 10.1038/s41598-019-57040-3.
5
Genotypic and phenotypic spectra of FGFR1, FGF8, and FGF17 mutations in a Chinese cohort with idiopathic hypogonadotropic hypogonadism.在中国特发性低促性腺激素性性腺功能减退症患者中,FGFR1、FGF8 和 FGF17 基因突变的基因型和表型谱。
Fertil Steril. 2020 Jan;113(1):158-166. doi: 10.1016/j.fertnstert.2019.08.069. Epub 2019 Nov 17.
6
Identification of a Novel CNV at 8q13 in a Family With Branchio-Oto-Renal Syndrome and Epilepsy.鉴定一个家族性的Branchio-Oto-Renal 综合征伴癫痫的 8q13 号新型 CNV
Laryngoscope. 2020 Feb;130(2):526-532. doi: 10.1002/lary.27941. Epub 2019 Mar 25.
7
Kallmann syndrome: phenotype and genotype of hypogonadotropic hypogonadism.卡尔曼综合征:低促性腺激素性性腺功能减退症的表型和基因型。
Metabolism. 2018 Sep;86:124-134. doi: 10.1016/j.metabol.2017.10.012. Epub 2017 Nov 3.
8
Analysis of genetic and clinical characteristics of a Chinese Kallmann syndrome cohort with mutations.具有突变的中国卡尔曼综合征队列的遗传和临床特征分析
Eur J Endocrinol. 2017 Oct;177(4):389-398. doi: 10.1530/EJE-17-0335. Epub 2017 Aug 5.
9
The effects of structure on pre-mRNA processing and stability.结构对前体信使核糖核酸加工及稳定性的影响。
Methods. 2017 Aug 1;125:36-44. doi: 10.1016/j.ymeth.2017.06.001. Epub 2017 Jun 6.
10
A dominant negative FGFR1 mutation identified in a Kallmann syndrome patient.在一名卡尔曼综合征患者中鉴定出一种显性负性FGFR1突变。
Gene. 2017 Jul 20;621:1-4. doi: 10.1016/j.gene.2017.04.017. Epub 2017 Apr 11.

在中国先天性低促性腺激素性性腺功能减退症大队列患者中发现的变异。

variants in a large cohort of Chinese patients with congenital hypogonadotropic hypogonadism.

机构信息

School of Life Sciences, Central South University, Changsha 410078.

Hunan Key Laboratory of Medical Genetics, Changsha 410078.

出版信息

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Jul 28;47(7):847-857. doi: 10.11817/j.issn.1672-7347.2022.220071.

DOI:10.11817/j.issn.1672-7347.2022.220071
PMID:36039580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10930292/
Abstract

OBJECTIVES

Congenital hypogonadotropic hypogonadism (CHH) is a rare congenital gonadal dysplasia caused by defects in the synthesis, secretion or signal transduction of hypothalamic gonadotropin releasing hormone. The main manifestations of CHH are delayed or lack puberty, low levels of sex hormones and gonadotropins, and may be accompanied with other clinical phenotypes. Some patients with CHH are also accompanied with anosmia or hyposmia, which is called Kalman syndrome (KS). , located on X chromosome, is the first gene associated with CHH in an X-linked recessive manner. This study aims to provide a basis for the genetic diagnosis of CHH by analyzing the gene variant spectrum of in CHH and the relationship between clinical phenotype and genotype.

METHODS

In this study, whole exome sequencing (WES) was used to screen rare sequencing variants (RSVs) of in a Chinese cohort of 165 male CHH patients. Four commonly used tools were used to predict the function of the identified RSVs in coding region, including Polyphen2, Mutation Taster, SIFT, and Combined Annotation Dependent Depletion (CADD). Splice Site Prediction by Neural Network (NNSPLICE) was employed to predict possibilities of intronic RSVs to disrupt splicing. American College of Medical Genetics and Genomics (ACMG) guidelines was used to assess the pathogenicity of the detected RSVs. The genetic variant spectrum of CHH patients in Chinese population was established. The relationship between clinical phenotype and genotype was analyzed by collecting detailed clinical data.

RESULTS

Through WES analysis for 165 CHH patients, RSVs were detected in 17 of them, with the frequency of 10.3%. A total of 13 RSVs were detected in the 17 probands, including 5 nonsense variants (p.T76X, p.R191X, p.W257X, p.R262X, and p.W589X), 2 splicing site variants (c.318+3A>C, c.1063-1G>C), and 6 missense variants (p.N402S, p.N155D, p.P504L, p.C157R, p.Q635P, and p.V560I). In these 17 CHH probands with RSVs, many were accompanied with other clinical phenotypes. The most common associated phenotype was cryptorchidism (10/17), followed by unilateral renal agenesis (3/17), dental agenesis (3/17), and synkinesia (3/17). Eight RSVs, including p.T76X, p.R191X, p.W257X, p.R262X, p.W589X, c.318+3A>C, c.1063-1G>C, and p.C157R, were predicted to be pathogenic or likely pathogenic RSVs by ACMG. Eight CHH patients with pathogenic or likely pathogenic variants had additional features. In contrast, only one out of nine CHH patients with non-pathogenic (likely benign or uncertain of significance) variants according to ACMG exhibited additional features. And function of the non-pathogenic ANOS1 variants accompanied with other CHH-associated RSVs.

CONCLUSIONS

The genetic spectrum of CHH patients in Chinese population is established. Some of the correlations between clinical phenotype and genotype are also established. Our study indicates that CHH patients with pathogenic or likely pathogenic RSVs tend to exhibit additional phenotypes. Although non-pathogenic variants only may not be sufficient to cause CHH, they may function together with other CHH-associated RSVs to cause the disease.

摘要

目的

先天性低促性腺激素性性腺功能减退症(CHH)是一种罕见的先天性性腺发育不良,由下丘脑促性腺激素释放激素的合成、分泌或信号转导缺陷引起。CHH 的主要表现为青春期延迟或缺乏、性激素和促性腺激素水平低,并可能伴有其他临床表型。一些 CHH 患者还伴有嗅觉缺失或嗅觉减退,称为卡尔曼综合征(KS)。位于 X 染色体上的 是第一个与 X 连锁隐性方式相关的 CHH 基因。本研究旨在通过分析 CHH 患者中 基因变异谱以及临床表型与基因型的关系,为 CHH 的遗传诊断提供依据。

方法

本研究采用全外显子组测序(WES)筛选了 165 例中国男性 CHH 患者中罕见的编码区序列变异(RSVs)。使用四种常用的工具,包括 Polyphen2、Mutation Taster、SIFT 和 Combined Annotation Dependent Depletion(CADD),预测鉴定出的 RSVs 在编码区的功能。采用神经网络(NNSPLICE)预测内含子 RSVs 对剪接的影响。采用美国医学遗传学与基因组学学院(ACMG)指南评估检测到的 RSVs 的致病性。建立了中国人群 CHH 患者的 基因变异谱。通过收集详细的临床数据,分析临床表型与基因型的关系。

结果

通过对 165 例 CHH 患者的 WES 分析,在 17 例患者中检测到 RSVs,频率为 10.3%。在这 17 名先证者中,共检测到 13 种 RSVs,包括 5 种无义变异(p.T76X、p.R191X、p.W257X、p.R262X 和 p.W589X)、2 种剪接位点变异(c.318+3A>C、c.1063-1G>C)和 6 种错义变异(p.N402S、p.N155D、p.P504L、p.C157R、p.Q635P 和 p.V560I)。在这 17 名携带 RSVs 的 CHH 先证者中,许多伴有其他临床表型。最常见的相关表型是隐睾(10/17),其次是单侧肾发育不全(3/17)、牙齿缺失(3/17)和联带运动(3/17)。包括 p.T76X、p.R191X、p.W257X、p.R262X、p.W589X、c.318+3A>C、c.1063-1G>C 和 p.C157R 在内的 8 种 RSVs 被 ACMG 预测为致病性或可能致病性的 RSVs。8 名携带致病性或可能致病性 变异的 CHH 患者具有额外的特征。相比之下,根据 ACMG 标准,9 名携带非致病性(可能良性或意义不明) 变异的 CHH 患者中只有 1 名表现出额外的特征。并且非致病性 ANOS1 变异与其他 CHH 相关的 RSVs 共同作用。

结论

建立了中国人群 CHH 患者的 基因变异谱。还建立了一些临床表型与基因型之间的相关性。我们的研究表明,携带致病性或可能致病性 RSVs 的 CHH 患者往往表现出额外的表型。虽然非致病性 变异可能不足以导致 CHH,但它们可能与其他 CHH 相关的 RSVs 共同作用导致疾病。